Abdul Ali A Peer Zada

Dr. Abdul Ali A Peer Zada

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
HAHamoud Alhebbi
Hamoud Alhebbi
AZAbdul Ali A Peer Zada
Abdul Ali A Peer Zada
AAAbdulrahman A. Al‐Hussaini
Abdulrahman A. Al‐Hussaini
SASara Algubaisi
Sara Algubaisi
AAAwad Albassami
Awad Albassami
NANaif Almontashiri
Naif Almontashiri

1 December 2021 in International Journal of Pediatrics and Adolescent Medicine
Verified
Journal Article
Open access
MAMohammed Alzaid
Mohammed Alzaid
KAKhalid Al-Mobaireek
Khalid Al-Mobaireek
MAMohammed Almannai
Mohammed Almannai
GMGawahir Mukhtar
Gawahir Mukhtar
SESafa Eltahir
Safa Eltahir
WAWadha Alotaibi
Wadha Alotaibi
Background: Primary ciliary dyskinesia (PCD) is a ciliopathy with diverse clinical and genetic findings caused by abnormal motile cilia structure and function. In this study, we describe the clinical characteristics of confirmed PCD cases in our population and report the radiological, genetic, and laboratory findings. Methods: This was a retrospective, observational, single-centre study. We enrolled 18 patients who were diagnosed with confirmed PCD between 2015 and 2019. We then analyzed their data, including clinical findings and workup. Results: In our cohort, 56% of patients had molecularly confirmed PCD, and RSPH9 was the most common gene identified. Transmission electron microscopy (TEM) showed an ultrastructural defect in 64% of samples, all of which matched the genetic background of the patient. Situs inversus (SI) was observed in 50% of patients, and congenital heart disease was observed in 33%. The median body mass index (BMI) was 15.87 kg/m2, with a median z score of -1.48. The median FEV1 value was 67.6% (z score - 2.43). Radiologically, bronchiectasis was noted in 81% of patients at a variable degree of severity. Lung bases were involved in 91% of patients. We were unable to correlate the genotype-phenotype findings. Conclusion: We describe the clinical and molecular characteristics of patients with confirmed PCD in a tertiary centre in Saudi Arabia and report 9 new pathogenic or likely pathogenic variants in one of the PCD-associated genes.

14 May 2024 in Clinical Case Reports
Verified
Journal Article
Open access
RARagdah M. Alamri
Ragdah M. Alamri
MAMaryam Alanazi
Maryam Alanazi
RARajeh K. AlRajeh
Rajeh K. AlRajeh
STSuha A. Tashkandi
Suha A. Tashkandi
AAAzizah F. Alswayyed
Azizah F. Alswayyed
AZAbdul Ali A Peer Zada
Abdul Ali A Peer Zada
Key Clinical Message: In a patient with de novo AML, co‐existing BCR::ABL1 p190 isoform and RUNX1::MECOM rearrangement is accompanied by a very poor prognosis including limited response to treatment and no molecular remission. It is essential to develop a consensus on the therapeutic modalities different from the current regimen. Acquisition of BCR::ABL1 fusion as a primary or secondary event and RUNX1::MECOM fusion independently is reported in de novo and therapy‐related MDS/AML, albeit with low frequency (<0.5%). Coexistence of BCR::ABL1 and MECOM translocation is known to cause leukemogenesis in animal models and progression towards blast crisis CML but not AML. Here we report a unique case of pediatric AML with concomitant BCR::ABL1 and RUNX1::MECOM fusion.Routine diagnostic work‐up included WBC manual differential, immunophenotype, morphology, qPCR, FISH, and NGS‐based CNV analyses. The patient presented with history of fever, dizziness, fatigue, gingival bleeding, and epistaxis associated with ecchymosis in right hand and heavy, prolonged menstrual period. At presentation, her hemoglobin was 5.3 g/dL, WBC 52.1(10*9/L), PLT 10(10*9/L), ESR 5 mm/h and LDH 2658 U/L. Bone marrow was hypercellular with 71% blasts, and flow cytometry showed myeloid markers including CD11c, CD33, CD34, and CD45 among others indicating AML with monocytic differentiation. FISH analyses showed variant t(9;22) (q34.1;q11.1), one additional copy each of chromosome 8 and Runx1 gene, while NGS‐based CNV analyses revealed a terminal and proximal pathogenic gain within 9q34.12q34.3 and 22q11.1q11.23, respectively, and gain of entire chromosome 8 and 12 in mosaic state. qPCR confirmed the presence of p190 and also revealed RUNX1::MECOM fusion. Patient received ADE (cytarabine, daunorubicin, and etoposide) induction regimen but required multiple ICU admissions due to sepsis, cardiac shock, acute myocarditis, and thyroiditis. Coexisting BCR::ABL1 and RUNX1::MECOM fusion is suggestive of poor prognosis, and a need for consensus on the treatment modalities other than the current regimen is warranted.

Verified
Journal Article
Open access
PDF file
AAAbdullah Alshehri
Abdullah Alshehri
AZAbdul Ali A Peer Zada
Abdul Ali A Peer Zada
AAAbeer A. Algadhi
Abeer A. Algadhi
AAAbdulwahed Aldehaimi
Abdulwahed Aldehaimi
MSMohammed A. Saleh
Mohammed A. Saleh
AAAli M. AlAsmari
Ali M. AlAsmari
Inborn errors of metabolism (IEM) and endocrine disorders are common genetic conditions in the Saudi population with the incidence rate often underestimated. Newborn screening (NBS) using various disease panels provides the first line in the early detection and intervention among infants with a high risk of IEM. Here we aim to assess the incidence of screening disorders and provide an overview of the NBS program at the Ministry of Health Tertiary Care King Fahad Medical City. Dried blood spots (DBS) from 40,965 newborn infants collected on the second day after birth were analyzed for 20 disorders. The total number of positive screen (“repeat”) samples over 10 years was about 1% (n = 382/40,965). The true positive result rate was 15.3% (n = 46/301) with the recall rates of individual disorders ranging from 0.26% (95% CI, 0.17–0.69) to 2.6% (95% CI, 2.19–3.05). The false positive result rate was 84.7% (n = 255/301) with biotinidase activity found to be the most common cause of the second sample repeat. The overall incidence of the screened diseases was 1:891 (95% CI, 11.61–12.47). CH and CAH are the most prevalent among endocrine disorders with an incidence of 1:4097 (95% CI, 2.19–3.05), and PA and ASA among the IEM with an incidence of 1:10,241 (95% CI, 0.09–0.95). In summary, we provide updated data and our experience on the incidence of various IEM and endocrine disorders among the Saudi population, highlight the role of false positive results of biotinidase activity that can increase the recall rate and lead to overestimation of the incidence data, and recommend multicenter studies to achieve a successful national NBS program.

1 March 2022 in Clinical Case Reports
Verified
Journal Article
Open access
RAReem Al‐Shaikh
Reem Al‐Shaikh
DADimah Alnowaiser
Dimah Alnowaiser
AZAbdul Ali A Peer Zada
Abdul Ali A Peer Zada
AAAwatif Almutairi
Awatif Almutairi
HAHamza Alghamdi
Hamza Alghamdi
Herein, we report a case of VAIHS with atypical clinical presentation of perianal abscess, fistula fever, and bi‐cytopenia including pathogenic ADA2 mutation suggesting that ADA2 deficiency be considered as a differential diagnosis of enlarging cutaneous abscess with no evidence of wound healing in the setting of leukopenia and neutropenia.

19 June 2023 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
MAMANAL ABUDAWOOD
MANAL ABUDAWOOD
HAHanan Alorini
Hanan Alorini
MSManar A. Samman
Manar A. Samman
SBSalman M. Bashir
Salman M. Bashir
AAAzizah AlSwayed
Azizah AlSwayed
AZAbdul Ali A Peer Zada
Abdul Ali A Peer Zada
Three major PML-RARα fusion gene transcripts (long [bcr1], variant [bcr2], and short [bcr3]) are currently used in clinical laboratories for the diagnosis and treatment monitoring of APL patients. Despite highly improved outcome, relapse and intracranial haemorrhage that may lead to early death is still an unsolved complication in APL. We reviewed APL patients confirmed by qPCR for the presence of PML-RARα transcripts (n = 27) and studied their outcome in relation to the isoform expression at diagnosis and follow-up in King Fahad Medical City. Eight in twenty-seven patients showed bcr3 and nineteen patients with bcr1 as major isoforms at diagnosis. Half of the bcr3 patients (n = 4/8) showed early mortality, prolonged qPCR positivity, 4-fold higher neutrophil/lymphocyte ratio, higher creatinine levels, and significantly reduced relapse free and overall survival time compared with bcr1 patients. Radiological findings in bcr3 patients revealed CNS involvement in the form of intracranial haemorrhage and periventricular microangiopathy and no CNS involvement in bcr1 patients. In conclusion, PML-RARα isoform expression at diagnosis in selective patients influences disease course over time and may even lead to early mortality due to haemorrhage. Thus, timely reporting of the specific PML-RARα isoform by clinical laboratories and CNS assessment by radiology can prevent complications leading to death in some APL patients.